All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Nalirifox
Zymet
Zidesamtinib
Tarlatamab
Velo
3 Herizon GEA 01
Tislelizumab
Herizon GEA 01 2026
新药靶点发现与验证
Zanidatamab
Target
Toripalimab
Zanidatamab
MOA
Jazz Pharma
肺癌微乳头型 30 国外
PeerView Oncology
Jazz Pharmaceuticals
Quizartinib
Zyme
Zanidatamab
Phase 2
Zanidatamab
vs Enhertu
Tdxd vs Zanidatamab
in Gastric Cancer
Zanidatamab
Pronounce
Zenocutuzumab
AM a HAL Bertrand Smo
Zanidatamab
Tebentafusp
Test Her2 HD
Zantac Recall. News
Zanidatamab
BTC
Nct02317939
HER2 Testing Ventana
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Nalirifox
Zymet
Zidesamtinib
Tarlatamab
Velo
3 Herizon GEA 01
Tislelizumab
Herizon GEA 01 2026
新药靶点发现与验证
Zanidatamab
Target
Toripalimab
Zanidatamab
MOA
Jazz Pharma
肺癌微乳头型 30 国外
PeerView Oncology
Jazz Pharmaceuticals
Quizartinib
Zyme
Zanidatamab
Phase 2
Zanidatamab
vs Enhertu
Tdxd vs Zanidatamab
in Gastric Cancer
Zanidatamab
Pronounce
Zenocutuzumab
AM a HAL Bertrand Smo
Zanidatamab
Tebentafusp
Test Her2 HD
Zantac Recall. News
Zanidatamab
BTC
Nct02317939
HER2 Testing Ventana
Zanidatamab
Journal Club
Enhertu Mechanism of Action
Cancer Trial B7-H4
Herceptin Mechanism of Action
Jve D1g1ta1 Med1a
The Her 2 Negative
Zantac Recall News 2013
Beone Medicines
Hrii
eGFR Lapatinib
Tfap2b Drug
Mechanism of Action Herceptin Perjeta
Tscib
Mechanism of Action Trastuzumab
Trastuzumab vs Pertuzumab
Her2
Yan Ji MD Oncology Reviews
Her2 Low
Mode of Action of Trastuzumab Emtansine
Ziihera Zanidatamab
Hrii
0:44
Dr Montero on the Rationale for Evaluating Zanidatamab/Evorpacept in HER2 Metastatic Breast Cancer | OncLive
Mar 18, 2025
onclive.com
HERIZON-GEA-01: Zanidatamab ± Tislelizumab vs Trastuzumab Chemotherapy in HER2 Gastric/GEJ Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
5 months ago
targetedonc.com
8:01
Zanidatamab in Previously-Treated HER2-Positive (HER2 ) Biliary Tract Cancer (BTC): Overall Survival (OS) and Longer Follow-up From the Phase 2b HERIZON-BTC-01 Study | OncLive
Jun 27, 2024
onclive.com
Dr Elimova on the Efficacy of Zanidatamab With Chemotherapy in HER2 Advanced/Metastatic Gastroesophageal Adenocarcinoma | OncLive
11 months ago
onclive.com
1:55
Ian Krop, MD, PhD, of Yalemed Cancer Center discusses zanidatamab in combination with evorpacept in HER2-positive and HER2-low metastatic breast cancer. Watch more here: https://hubs.ly/Q035PH6_0 | OncLive
115 views
Feb 8, 2025
Facebook
OncLive
Dr Montero on Zanidatamab and Evorpacept in HER2-Expressing Metastatic Breast Cancer | OncLive
Jan 15, 2025
onclive.com
Dr. Ku on Evaluating Zanidatamab Plus Chemotherapy in HER2-Expressing GEA | OncLive
Oct 27, 2021
onclive.com
3:27
Dr Elimova on Key Data for Zanidatamab-Based Combos in HER2 Gastroesophageal Adenocarcinoma | OncLive
4 months ago
onclive.com
1:10
Dr Harding on the FDA Approval of Zanidatamab for HER2 Biliary Tract Cancer | OncLive
Nov 23, 2024
onclive.com
5:05
Sequencing and Next Steps for Zanidatamab in Her2-Positive Gastric Cancer
995 views
3 months ago
YouTube
OncUpdates: Latest Oncology Insights
1:34
Zanidatamab and chemotherapy in HER2+ gastroesophageal cancer
639 views
May 3, 2023
YouTube
VJOncology
24:03
HERIZON-GEA-01: Zanidatamab in Frontline Therapy for HER2-Positive Gastric and GEJ Cancer
4.3K views
4 months ago
YouTube
OncBrothers: Practice-Changing Cancer Discu…
4:16
HERIZON-GEA-01: zanidatamab ± tislelizumab & chemotherapy for HER2+ GEA
49 views
2 months ago
YouTube
VJOncology
7:43
Managing Efficacy and Toxicity With Zanidatamab in HER2-Positive Disease
684 views
3 months ago
YouTube
OncUpdates: Latest Oncology Insights
Jazz Pharmaceuticals plc to Present Pivotal Phase 3 Results of Ziihera®? (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCOGastrointestinal Cancers Symposium
5 months ago
marketscreener.com
0:59
Zanidatamab Combinations in Frontline HER2+ Gastroesophageal Cancer
74 views
2 months ago
YouTube
OncUpdates: Latest Oncology Insights
15:06
Managing Side Effects of HER2 Targeted Therapy - Zanidatamab & Trastuzumab deruxtecan (T-DXd)
3.1K views
May 8, 2025
YouTube
OncBrothers: Practice-Changing Cancer Discu…
Dr Pant on the Investigation of Zanidatamab in Biliary Tract Cancer | OncLive
Jun 9, 2023
onclive.com
7:20
Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer
14 views
2 weeks ago
YouTube
ecancer
3:46
HERIZON-GEA-01: zanidatamab + chemotherapy +/- tislelizumab improves PFS in 2L HER2+ mGEA
115 views
4 months ago
YouTube
VJOncology
Approaching First-Line Treatment in PD-L1 CPS <1 HER2-Positive GEA | OncLive
2 weeks ago
onclive.com
1:28
Shruti Patel, MD | GI Oncology on Instagram: "Late post from @ascocancer #GI26 but huge news in HER2-positive stomach and esophageal cancer!! A new HER2-targeted therapy (zanidatamab) just showed better results than trastuzumab AKA the drug we’ve relied on for more than 10 years. Both combinations (with chemo, and with chemo + immunotherapy) beat chemo + trastuzumab in a major Phase 3 trial. No numbers yet, but the signal is clear: this could become the new first-line treatment and finally move
2K views
4 months ago
Instagram
shrutipatelmd
Zymeworks Inc.: Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3 ) Biliary Tract Cancer
1 year ago
finanznachrichten.de
Zymeworks Inc.: FDA Grants U.S. Approval of Ziihera (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3 ) Biliary Tract Cancer (BTC)
Nov 21, 2024
finanznachrichten.de
1:31
ZIIHERA® (zanidatamab-hrii)- biliary tract cancer
467 views
Jan 7, 2025
YouTube
Pharmacy Talk USA
0:43
🚨 Zanidatamab Injection (Ziihera) aprobado en China 💉 Innovador anticuerpo monoclonal que ataca específicamente los tumores HER2 . 🎯 Indicación: Para cáncer biliar localmente avanzado o metastásico con HER2 (IHC3 ). ⏳ Pacientes elegibles: Aquellos que ya recibieron tratamientos sistémicos previos, ofreciendo una nueva opción cuando otras terapias son limitadas. 📎 Más información: https://dengyuemed.com/product/zanidatamab-hrii-biliary-tract-cancer/ 📧
[email protected]
#ZanidatamabInjectio
15 views
6 months ago
Facebook
Sheldon Dengyuemed
#samcytryn #oncology #cancer #gastriccancer #her2 #trastuzumab #trastuzumabderuxtecan #zanidatamab | Rohit Gosain, MD
1 views
2 months ago
linkedin.com
3:11
Zanidatamab investigated for HER2+ advanced or metastatic gastro-oesophageal adenocarcinoma
224 views
Sep 20, 2024
YouTube
ecancer
3:19
Zanidatamab, palbociclib and fulvestrant show positive results in treating HER2+/HR+ mBC
113 views
Feb 20, 2024
YouTube
ecancer
1:45
Coronation Street legend 'completely wiped out' by cancer results
1 month ago
The Independent
Ella Pickover
See more
More like this
Feedback